ACVR1 and seminoma: The potential involvement of activin A signaling in TGCTs was demonstrated through immunohistochemical localization of activin type I (ALK2 and ALK4) and type II receptors (ActRIIB) in GCNIS, seminoma and non-seminoma cells (86).